Renal - Week 3 Flashcards

(72 cards)

1
Q

describe acid production in the body

A

• Cellular respiration
o Produces CO2 which reacts with water to form carbonic acid

• Metabolic processes
o Give rise to non-volatile acids: ketones, lactate etc
o ~60 mmol non-volatile acids per day
o In 14L this would make the body pH 2.3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

describe how acid homeostasis is maintained

A

• Buffers (rapid)
o Bind to protons to reduce acidity
o Proteins e.g. Hb
o Bicarbonate

• Lungs (fast)
o Remove CO2
o Limited by HCO3 reserves

• Kidneys (slow)
o Excrete H into urine
o Recover HCO3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what happens in hypoventilation

A
  • Increased CO2  respiratory acidosis
  • Lung disease, airway obstruction, neurological problem leading to depressed breathing such as head injury or opiate overdose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what happens in hyperventilation

A
  • Less CO2  respiratory alkalosis

* Panic attack in response to pain or asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how can you get metabolic acidosis

A

• Increased protons
o Over production of acid such as lactic acidosis (tissue hypoxia) or ketoacidosis (diabetes, starvation, alcohol)
o Impaired excretion
 Acute kidney injury or CKD

• Losing bicarbonate
o Severe diarrhoea
o Fistula formation in small bowel
o renal tubular acidosis type II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how can you get metabolic alkalosis

A
•	Unusual loss of protons
o	Vomiting
o	Severe hyperkalaemia
o	Hyperaldosteronism 
•	Unusual ingestion of bicarbonate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the compensation mechanisms for each acid base disturbance

A

metabolic acidosis

  • increased RR to lower CO2
  • increased renal recovery of HCO3

metabolic alkalosis

  • decreased RR to increase CO2
  • decreased renal recovery of HCO3
  • usually marginal

respiratory acidosis
- increased renal recovery of HCO3

respiratory alkalosis

  • decreased renal recovery of HCO3
  • usually marginal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how is HCO3 calculated

A

using the henderson-hasselbalch equation

CO2 + H2O H2CO3 H + HCO3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is important to remember about arterial blood gases

A

Blood gases often performed on the radial artery – can damage artery
Need to be analysed asap and not sent by pneumatic tube – pressure
We only need H, pO2, pCO2 and HCO3
Base excess and HCO3 are calculated by the analyser
Base excess is the amount of H per L of blood, required to return the pH to reference range at pCO2 of 5.3kPa
Should only be deranged where a metabolic disorder is present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe standardised bicarbonate

A
  • What the HCO3 conc would be if pCO2 were reference range (5.3kPa)
  • Std bicarb should only be deranged where a metabolic disorder is present
  • Purely metabolic disorder - approx. equivalent to actual bicarb
  • Mixed resp-meta disorder - significant difference to actual bicarb
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the effects of metabolic acidosis

A

• Cardiovascular
o Negative inotropic effect (if severe)

• Oxygen delivery
o Acutely – H causes R-shift of oxyHb dissociation curve (facilitates oxygen delivery)
o After several hours – H reduces 2,3-DPG causing L-shift of curve (impairs O2 delivery)

• Nervous system
o Impaired consciousness

• Potassium homeostasis
o H leakage from cells causing high plasma K, may also be lost renally
o If above sustained, total body K can be depleted

• Bone
o If chronic, acidosis can get buffered by bone
o Leads to decalcification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describe the relationship between metabolic acidosis and anion gap

A

some causes have anion gap and some done

elevated
o DKA
o lactic acidosis
o salicylate overdose
o ethylene glycol, methanol poisoning
o renal failure

normal
o severe diarrhoea
o high intestinal fitula output
o renal tubular acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the effects of respiratory acidosis

A

hypercapnia -
o shortness of breath
o neurological - anxiety, coma, headache, myoclonus
o systemic vasodilation

o hypoxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the effects of metabolic alkalosis

A

not usually significant
K moves into cells

beware effect of IV bicarbonate in CKD as metabolic acidosis is common in CKD - acute fall in acidity can reduce solubility of calcium salts and increase risk of systemic calcification

Remember the compensation for alkalosis is limited

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the effects of respiratory alkalosis

A

acute hypocapnia
o cerebral vasoconstriction - light headedness, fits, confusion, syncope
o fall in ionised calcium -perioral, peripheral parasthesia

cardiovascular
o increased heart rate
o vasoconstriction - possible angina in those with coronary artery disease

Remember the compensation for alkalosis is limited

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how can you get respiratory acidosis

A
acute
o airway obstruction
o  cardio-resp  arrest
o infective exacerbation of COPD 
o pneumonia
o neurological - opiate toxicity, guilllain barre syndrome, myasthenia gravis
chronic
o COPD
o obstructive - obesity
o restrictive -  pulmonary fibrosis
o neurological -  MND,  myopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

how can you get respiratory alkalosis

A
usually acute in nature
o asthma, COPD. PE
o pain, panic attack
o iatrogenic 
o altitude sickness

o inappropriate stimulation of respiratory centre
• head injury
• raised ICP
• local tumour
• metabolic e.g. hepatic encephalopathy, poisoning

chronic
o pregnancy - mild resp alkalosis compensated by minor metabolic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what are the immune systems normal functions?

A

Recognition of ‘non-self’or ‘abnormal self’
Protection from pathogens (bacteria, viruses etc)
Surveillance for tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what are the components of the immune system

A

Innate immune system

Macrophages
Neutrophils
Complement & natural antibodies (IgM)

Adaptive immune system

 Dendritic cells (antigen presentation)
 T cells (helper and cytotoxic T cells)
 Natural Killer (NK) cells - cytotoxic
 B cells (antibody generation & memory)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

describe MHC (Major Histocompatibility Complex)

A

MHC in humans called Histocompatibility Locus Antigen (HLA)
These molecules imprint ‘individuality’ on cells and are pivotal in the generation of immune responses
HLA genes are very polymorphic i.e. there are many different variations possible at each gene locus

Class I molecules: HLA-A, -B and -C
Expressed by most somatic cells of body
Used to present peptides from internally processed proteins
Class II: HLA-DP, -DQ and –DR
Expressed by Antigen Presenting Cells (DCs etc) that constantly ’sample’ their microenvironment
Used to present antigenic peptides derived from digested material (including pathogens, abnormal or foreign cells)

Class I: HLA-A, -B and -C
If Class 1 HLA molecule is associated with virus-derived protein then the cell is recognised as infected
Infected cell will be killed by cytotoxic T cells

Class II: HLA-DP, -DQ and –DR
Used by Antigen Presenting Cells (DCs etc) to present antigenic peptides derived from digested and processed material
Cell surface expression of a peptide derived from a pathogen or foreign cell will stimulate a T cell immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what are the key principles of transplant immunology

A

Rejection of Tx is directed at specific proteins called antigens
Rejection is donor specific
Rejection may be both Cell or Antibody mediated
Rejection exhibits ‘memory’ i.e. a 2nd similar Tx is rejected MORE RAPIDLY and this results from the rapid generation of cytotoxic antibodies that recognise the Tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

describe HLA profiling

A

Performed using molecular biological and serological techniques
e.g. HLA-A1 and A3,
HLA-B44 and B44
HLA-DR7 and DR15
The HLA tissue types of all patients on the Kidney Transplant waiting list is held on a central UK database and the ‘best match’ chosen when kidneys become available
Used to allocate kidneys but less important for other organs such as liver (less immunogenic)
If all HLA-A, -B and –DR loci are the same the it is a 0-0-0 mismatch
If they are all different then it is a 2-2-2 mismatch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

describe immunosuppressive treatment

A

Corticosteroids
Kill lymphocytes
Interfere with T cell activation and gene transcription
Powerful anti-inflammatory agents

Calcineurin inhibitors (CNI) – Tacrolimus
 Inhibit T cell activation by interfering with intracellular signaling pathways

Anti-proliferative agents - mycophenolate mofetil (MMF)
Inhibit clonal expansion of T cells

Various monoclonal and polyclonal antibodies directed against:
IL-2 receptor blockers (IL-2 stimulates clonal expansion of T cells)
T cells (cytotoxic complement fixing Abs)
Co-stimulatory molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

which organs are transplantable

A
Kidney
Pancreas (complete organ or pancreatic islets)
Liver
Lung
Heart
Small Bowel
Cornea
Faces, arms etc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
what needs to be assessed in patients needing a transplant
Age important (biological vs chronological!) - frailty Primary cause of renal failure e.g. polycystic kidneys versus conditions which can recur in a Tx (e.g. aHUS, FSGS) Comorbid disease e.g. cardiovascular disease (IHD, PVD), diabetes etc History of infections History of tumours (need tumour free period) Urological disease e.g. bladder dysfunction Additional investigations: CARDIAC - exercise ECG, myocardial perfusion studies Angiography (need decent vessels for the anastomosis) Urodynamic studies Tumour markers, imaging etc
26
what are the types of transplant?
``` Cadaveric Tx (commonest) e.g. subarachnoid haemorrhage • DCD = donated after cardiac death • DBD = donation after brain death Living related donor Tx • Sibling, spouse, altruistic Typically a kidney Tx ``` Live donation lasts longer than cadaveric
27
what are the criteria for a kidney Tx to go ahead?
Blood group (ABO) compatible (RIE now has an ABO incompatible programme) Immunological ‘X-match negative’ • Take serum from the recipient and donor lymphocytes • Add a complement e.g. vital dye which will enter killed cells and turn them a colour if they are matched to recipient antibodies
28
describe anti-HLA antibodies
If a person is exposed to a foreign HLA molecule, they can produce an HLA antibody against this e.g. patient is A1, A24 and with exposure to A31 generating an anti-A31 antibody Approximately 30% patients on renal waiting list have anti-HLA antibodies The ‘specificity’ of these antibodies has to be defined (e.g. A31, B8, DR3 etc) Highly sensitised patients exhibit high levels of cytotoxic Abs to many HLA antigens that may be derived from: • Previous transfusions (WBC filtered) • Pregnancies • Previous Transplantation
29
why do anti-HLA antibodies matter?
HLA antibody status requires careful consideration - make a successful X-match less likely (long wait for Tx) - can lead to antibody mediated rejection - Consider desensitisation/antibody removal or paired exchange Tx
30
what types of rejection are there
Hyperacute rejection (should not happen) Acute rejection Chronic rejection
31
describe HLA antibody detection
put beads with selected class I or II antigens into a well incubate this with patient serum wash incubate with PE conjugated anti-human IgG wash and then scan them. you can derive a graph from this to show how many antibodies they have to certain molecules
32
describe hyperacute rejection
Occurs when the Tx carries antigens to which the recipient is already sensitised Cytotoxic antibodies bind endothelial cells and induces complement activation, platelet aggregation and intravascular thrombus formation The Tx is often destroyed ‘on the operating table ``` Features: • Rise in creatinine (often only indication) • Reduced urine output • Tender transplant • Fever Exclude: • Dehydration (clinical examination, BP, weight) • Renal obstruction (ultrasound) • Vascular catastrophe (Doppler) • Drug toxicity (tacrolimus levels) ```
33
how do you treat acute rejection
``` High dose methyl prednisolone (anti-inflammatory, kills lymphocyte etc) Change to more potent immunosuppressive agent or an increased dose ‘Anti-T cell’ antibody (increased risk of infection, tumours) Plasma exchange (severe acute Ab mediated rejection) ```
34
describe chronic rejection and what do we need to exclude
Features: • Progressive renal dysfunction • Interstitial fibrosis and vascular disease on renal biopsy Need to exclude: • Recurrent disease (membranous, MCGN) • Obstruction (ultrasound) • Renal artery stenosis (Doppler of renal artery +/- MRI angiography)
35
what are the causes of chronic rejection
* Artery stenosis * Recurrent crescentic nephritis * Recurrent diabetic neuropathy * Interstitial fibrosis * Vasculopathy – can cause narrowed lumen of arteries
36
what is the pathogenesis of chronic rejection
Multifactorial: immune and non-immune mechanisms: Increased HLA mismatch (1-2-1 vs 0-0-1) Previous acute rejection Poor drug compliance (low tacrolimus levels) Prolonged cold ischaemia time of kidney prior to surgery (CIT of living donor << cadaveric donor)
37
what are some factors promoting graft failure
``` Delayed graft function Cytomegalovirus (CMV) infection Age of donor and ‘donor disease’ Poor blood pressure control Proteinuria ```
38
how do you manage chronic rejection
No specific treatment available Most patients will eventually require dialysis and potentially a further Tx Optimise immunosuppression Proactive treatment of BP, lipids, proteinuria etc
39
what are the infective risks of immunosuppression
Bacteria urinary tract infection, chest infection prophylactic cotrimoxazole Viral CMV, herpes virus, parvo virus, BK virus (causes renal dysfunction) prophylactic valgancyclovir if recipent CMV –ve and donor CMV +ve TB (may require prophylactic treatment)
40
what are the tumour risks of immunosuppression
Incidence of all cancers increased Skin cancers common (UV block, avoid sun, skin surveillance) Post Tx Lymphoproliferative Disorder (PTLD) – secondary to infection with Epstein Barr virus (reduce immunosuppression, may need chemotherapy)
41
what are some side effects of immunosuppressive drugs
Calcineurin inhibitors are nephrotoxic! Plasma levels of tacrolimus are measured regularly Increased risk of diabetes (steroids and tacrolimus) Hypertension (steroids and CNI) Osteoporosis (steroids)
42
What is AKI defined as?
any of the following: * Increase in serum creatinine by > 26.5 μmols/L in 48 hours or, * Increase in serum creatinine by > 1.5x baseline creatinine within last 7 days or * Urine volume < 0.5ml/kg/hr for 6 hours
43
what percentage of hospital inpatients does AKI affect
7%
44
what are the concequences of AKI
* Increased length of stay in hospital * Increased morbidity * Increased hospital & post-discharge mortality * Very costly (~£500 million/annum)
45
what are the differential diagnoses for pre-renal AKI
PRE-RENAL reduced real or ‘effective’ blood volume - Hypovolaemia e.g. bleeding, 3rd space fluid losses, over-enthusiastic diuretic therapy! - Hypotension e.g. septic/cardiogenic shock, liver failure - Reduced renal blood supply secondary to severe renovascular disease (±ACEI), dissection of the abdominal aorta etc
46
what are the differential diagnoses for renal AKI
RENAL glomerulus, tubules and interstitium • Acute tubular injury – Commonest cause of AKI in hospitals and can complicate everything previously discussed! – Tubular toxins, eg gentamicin, cisplatinum, NSAIDs, radio-contrast dye – Severe prolonged hypotension (sepsis, MI) – Renal hypoperfusion e.g. elderly patient on ACEI, diuretic who has D&V – Initial oliguria then may exhibit polyuric recovery phase (watch electrolytes) ``` Tubulointerstitial causes Acute allergic interstitial nephritis DRUG-RELATED e.g. PPIs, (omeprazole) antibiotics, diuretics, NSAIDs May have an eosinophilia (no rash) Often respond well to steroids ``` Examples of cresentic RPGN (rapidly progressing glomerular nephritis) Goodpasture’s syndrome: anti-GBM Ab Wegener’s granulomatosis: PR3 Ab Microscopic polyarteritis (MPA): MPO Ab SLE: Anti-nuclear Ab (ANA), anti-dsDNA Abs Vascular causes Haemolytic uraemic syndrome (HUS) E coli related (E coli O157) Familial cases (genetic aetiology) * Acute tubular injury - may follow severe hypotension * Rhabdomyolysis - crush injury or low lie on the floor * Contrast nephropathy * Interstitial nephritis - drugs e.g. penicillin, NSAIDs * Systemic vasculitis * Myeloma - tumour of plasma cells * Haemolytic uraemic syndrome - E. Coli O157 infection
47
what are the differential diagnoses for post-renal AKI
POST-RENAL obstruction – multiple levels (e.g. ureter, bladder etc) - Note that bilateral obstruction OR obstruction of a single kidney (transplant) is required in order to result in AKI Causes include: Prostate – hypertrophy (common), cancer Bladder lesions - tumour Ureter - calculi, tumour, extrinsic compression (retroperitoneal fibrosis, tumour Myeloma – proliferation of B cells in the bone marrow – these make a single antibody called a paraprotein which can precipitate and completely obstruct the lumen Hydronephrosis – very dilated due to an obstruction All patients with significant renal injury MUST have an ultrasound to exclude or demonstrate obstruction to the renal tract
48
what should be done with a patient with AKI
* Take a clinical history * Perform a clinical examination * Request appropriate investigations * Clinical history in AKI * Renal history – pre-existing renal disease, diabetes, family history * Urine volume - ?acute oliguria * Drug history – ? New drugs, nephrotoxic drugs (NSAIDs, ACEI, antibiotics) * Systemic symptoms – diarrhoea, rashes etc
49
what does a clinical examination involve in AKI
Fluid status (JVP, postural BP) ?dehydrated ?evidence of infection ?rash, joint pathology Arterial bruits ?underlying renovascular disease Palpable bladder (obstruction) Check drug chart!
50
what are investigations in AKI
``` Urine dipstick – simple BUT important (blood, protein) Urine culture Renal Ultrasound - if obstructed then decompress Renal biopsy (AKI and normal sized kidneys) Angiography ± intervention ```
51
what are the blood tests in AKI
FBC, blood film, clotting screen Biochemistry including Ca2+, PO42- LFTs and albumin Creatinine kinase (rhabdomyolysis) - black urine Blood cultures Virology and serology e.g Hep B, ASOT
52
what are the immunological tests in AKI
``` IgGs and serum electrophoresis (myeloma) Complement levels (SLE, post strep GN) Autoantibodies e.g. - Anti-nuclear factor (ANA) - SLE - Anti-neutrophil Ab (ANCA) - vasculitis - Anti-GBM Ab - Goodpasture’s syndrome, ```
53
what are some "other" tests in AKI
Urine: Bence Jones protein = light chains (myeloma) Chest X ray (cardiac size, pulmonary oedema or haemorrhage) ECG especially if hyperkalaemia
54
what is the general treatment for AKI
Optimise fluid balance and circulation Stop exacerbating factors e.g. nephrotoxic drugs (check drug charts) Appropriate prescribing (check BNF, discuss with pharmacist) e.g. opiates accumulate in AKI Supportive treatment e.g. dialysis, nutrition
55
what are some specific treatments for AKI
``` Obstruction - drain renal tract Sepsis - effective antibiotics Rapidly progressing glomerular nephritis RPGN e.g. SLE (systemic lupus erythematosus) - immunosuppression Goodpasture’s syndrome - Plasma exchange Compartment syndrome - fasciotomy ```
56
when to give dialysis
``` Severe ‘uraemia’: - no prospect of immediate improvement - uraemic encephalopathy or seizures - uraemic pericarditis Hyperkalaemia unresponsive to medical treatment (>6.5) ``` ``` Fluid overload, especially pulmonary oedema, resistant to treatment with diuretics/fluid restriction Severe acidosis (results in myocardial depression and hypotension) ```
57
complications with dialysis
Vascular access related complications - Pneumothorax Infection Bleeding Anticoagulation required which may be problematic in patients with bleeding. Hypotension may be troublesome in some patients (sepsis, IHD, diabetes)
58
describe hypovolaemia-initial fluid resuscitation
* 500 mL 0.9% sodium chloride or plasmalyte over 15 minutes * Reasonable to repeat if no response * Do not give more than 2000 mL as resuscitation fluid without senior input
59
what are drugs which make AKI worse
* ACE inhibitors and angiotensin receptor blockers * Blood pressure lowering drugs * Diuretics * Non-steroidal anti-inflammatory drugs (NSAIDs) * Radiocontrast agents
60
how to treat hyperkalaemia
(for those >6.5 mmol/L) • IV calcium salts if ECG abnormal • Lasts around 30 minutes * Insulin/glucose and nebulized salbutamol * Push potassium into cells * Lasts around 4-6 hours * Treat underlying cause * Need to get kidneys working to excrete potassium
61
how to diagnose systemic vasculitis
• Dipstick urinalysis * Serum anti-neutrophil cytoplasmic antibodies * Often present with coincident infection * Tissue diagnosis * Kidney most common * Lung * Nerve
62
how to treat systemic vasculitis
``` • Glucocorticoids • Oral prednisolone • Plasma Exchange • Significant renal disease and/or pulmonary haemorrhage ``` • Cyclophosphamide/Rituximab
63
what is important to remember in post-renal AKI
* Needs to block both kidneys to cause AKI * Some people have a single kidney * In women can be due to pelvis cancer-cervical, ovarian * Bladder tumours can also occlude ureteric orifice * Blood clot in bladder
64
what to do in the case of finding blood in protein in urine
• 2+ or more implies intrinsic renal disease and very unlikely to be explained by asymptomatic infection o The correct response to a finding of proteinuria is NOT to send an MSU “to exclude infection” • Quantify: albumin/creatinine ratio (timed collection rarely helpful) • Test kidney renal function, consider systemic diseases • NEVER ignore/dismiss it
65
describe the ranges of albuminuria
• Albumin/creatinine ratio (mg/mmol) can be performed on small urine sample taken at any time of day • ACR x 10 approximates to mg/24 hours (eg in renal disease 100 reflects c 1g/24h) • Normal ACR (eg) less than 3.5 o 3.5 – 30 microalbuminuria o > 30 (macro)albuminuria
66
what are measurements of excretory renal function
* plasma/serum creatinine * estimated GFR: MDRD formula (sex, age, race, creatinine) * creatinine clearance * isotope GFR (usually 51Cr EDTA)
67
what happens in congenital nephrotic syndrome
due to mutation in podocyte-specific gene eg nephrin
68
what is important in the case of blood and protein in urine
The presence of blood and protein in the urine implies glomerular disease and an urgent need to test excretory kidney function, consider systemic diseases such (eg vasculitis, lupus)
69
what can albuminuria suggest
* In diabetes mellitus, microalbuminuria is the earliest clinical feature of diabetic nephropathy; may initially be intermittent * In hypertension, albuminuria suggests a primary renal cause * In all patients, including in the absence of diabetes or hypertension, albuminuria carries prognostic significance Albuminuria is a potent, independent cardiovascular risk factor in both diabetic and non-diabetic populations. Aggressive management of cardiovascular risk is indicated.
70
what is nephrotic syndrome
* Clinical syndrome comprising oedema, heavy proteinuria, hypoalbuminaemia * Not included in the definition but often clinically important are thrombotic risk, propensity to infection and (often severe) hyperlipidaemia * May or may not be associated with impairment of excretory kidney function * Dominant symptoms often severe lethargy, reduced exercise tolerance, nausea, loss of appetite * Causes include glomerulonephritis, diabetes, infections (hepatitis B/C, malaria, HIV), amyloid
71
what is important in blood in urine
Haematuria, whether visible (macroscopic) or non-visible (microscopic) can be a sign of a serious systemic disease for which diagnosis and treatment is very urgent, whether or not there is also albuminuria don’t dismiss haematuria as “probably due to urine infection” without considering other possibilities: history, examination, investigations, possible specialist referral
72
diseases in which the glomerulus is damaged
(may present with proteinuria and/or haematuria) • Rare genetic/developmental disorders • Diabetes mellitus • Vascular disease/ischaemia/age • Inflammation of blood vessels “vasculitis isolated or as part of a systemic disease • Inflammation of glomerulus itself (“glomerulonephritis”, various types) • Deposition diseases eg amyloid,myeloma Anything which damages blood vessels